Antioxcin4 a New Mitochondriotropic Derivative Based on the Natural Polyphenol Caffeic Acid Reverts Cellular and Mitochondrial Metabolic Defects of Fibroblasts from Idiopathic Parkinson's Disease
AuthID
P-00V-2N6
P-00V-2N6